Symrise Sees Organic Growth Adj From 5-7% TO 3-5% IN 2025

Symrise AG SY1:

• SYMRISE - H1 EBITDA WAS €554 MILLION, 4.5% HIGHER THAN THE PREVIOUS YEAR'S FIGURE OF €530 MILLION

• SYMRISE - H1 EBITDA MARGIN INCREASED BY 100 BASIS POINTS TO 21.7% COMPARED TO THE PREVIOUS YEAR’S FIGURE OF 20.7%

• SYMRISE - FORECAST FOR 2025 EBITDA MARGIN OF AROUND 21% IS RAISED TO AROUND 21.5%

• SYMRISE - IN THE FIRST HALF OF 2025, SYMRISE ACHIEVED ORGANIC SALES GROWTH OF 3.1%

• SYMRISE - EXPECTED ORGANIC GROWTH ADJUSTED FROM 5-7% TO 3-5% IN 2025

• SYMRISE - REAFFIRMS ITS MEDIUM-TERM TARGETS UNTIL 2028